NCT00079625View on ClinicalTrials.gov

Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 5, 2004

Primary Completion Date

August 9, 2013

Study Completion Date

August 9, 2013

Conditions
Breast Neoplasms
Interventions
DRUG

Th2/Tc2 Cells

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00079625 - Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer | Biotech Hunter | Biotech Hunter